Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Peptic Ulcer

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 71 articles: HTML format

Single Articles

May 2024
1. SONODA M, Matsumura T, Dao HV, Shiko Y, et al
   A prediction model of abnormal acid reflux in gastroesophageal reflux disease.
   J Gastroenterol Hepatol. 2024 May 15. doi: 10.1111/jgh.16602.
   PubMed     Abstract available
   
   
   
2. KOUNTOURAS J, Zavos C, Vardaka E, Kyrailidi F, et al
   Helicobacter pylori and metabolic syndrome-related adipokines in nonalcoholic fatty liver disease pathophysiology.
   J Gastroenterol Hepatol. 2024 May 9. doi: 10.1111/jgh.16621.
   PubMed    
   
   
   
3. LOOSEN SH, Killer A, Luedde T, Roderburg C, et al
   Helicobacter pylori infection associated with an increased incidence of cholelithiasis: A retrospective real-world cohort study of 50 832 patients.
   J Gastroenterol Hepatol. 2024 May 7. doi: 10.1111/jgh.16597.
   PubMed     Abstract available
   
   
   
4. CHEUNG KS, Yan VKC, Ye X, Hung IFN, et al
   Proton pump inhibitors associated with severe COVID-19 among two-dose but not three-dose vaccine recipients.
   J Gastroenterol Hepatol. 2024 May 5. doi: 10.1111/jgh.16601.
   PubMed     Abstract available
   
   
   
5. ZHAO X, Ciren Y, Wu D
   Gastrointestinal: A rare intra-abdominal hydatid cyst manifesting as an acute massive upper gastrointestinal bleeding.
   J Gastroenterol Hepatol. 2024 May 2. doi: 10.1111/jgh.16579.
   PubMed    
   
   
   February 2024
6. SOGABE M, Okahisa T, Kagawa M, Sei M, et al
   Association of metabolic dysfunction-associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study.
   J Gastroenterol Hepatol. 2024 Feb 29. doi: 10.1111/jgh.16530.
   PubMed     Abstract available
   
   
   
7. YAMAOKA Y
   Revolution of Helicobacter pylori treatment.
   J Gastroenterol Hepatol. 2024 Feb 27. doi: 10.1111/jgh.16526.
   PubMed     Abstract available
   
   
   
8. KIM NH, Chang Y, Ryu S, Sohn CI, et al
   Impact of metabolic unhealthiness and its changes on the risk of erosive esophagitis: a cohort study.
   J Gastroenterol Hepatol. 2024 Feb 21. doi: 10.1111/jgh.16519.
   PubMed     Abstract available
   
   
   
9. SIMADIBRATA DM, Lesmana E, Fass R
   Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive esophagitis: A systematic review with meta-analysis of randomized controlled trials.
   J Gastroenterol Hepatol. 2024 Feb 14. doi: 10.1111/jgh.16486.
   PubMed     Abstract available
   
   
   
10. AYAR MS, Baydin A, Ustaoglu M, Caliskan F, et al
    Inferior vena cava collapsibility index and stroke volume as predictors of blood transfusion in upper gastrointestinal bleeding in the emergency department.
    J Gastroenterol Hepatol. 2024 Feb 9. doi: 10.1111/jgh.16500.
    PubMed     Abstract available
    
    
    January 2024
11. SIMADIBRATA DM, Lesmana E, Fass R
    A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease.
    J Gastroenterol Hepatol. 2024 Jan 23. doi: 10.1111/jgh.16475.
    PubMed     Abstract available
    
    
    
12. ZHUANG Q, Liao A, He Q, Liu C, et al
    The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study.
    J Gastroenterol Hepatol. 2024 Jan 22. doi: 10.1111/jgh.16471.
    PubMed     Abstract available
    
    
    
13. MUFTAH M, Hartnett DA, Flanagan R, Redd WD, et al
    Allergic phenotype identified on allergen testing is associated with proton pump inhibitor nonresponse in eosinophilic esophagitis.
    J Gastroenterol Hepatol. 2024 Jan 7. doi: 10.1111/jgh.16469.
    PubMed     Abstract available
    
    
    November 2023
14. SUN Y, Zhang A, Zuo M, Chen J, et al
    A pharmacovigilance study of association between proton-pump inhibitors and rhabdomyolysis event based on FAERS database.
    J Gastroenterol Hepatol. 2023 Nov 14. doi: 10.1111/jgh.16411.
    PubMed     Abstract available
    
    
    
15. BAILEY ME, Borges LF, Goldberg HJ, Hathorn KE, et al
    Abnormal bolus reflux on impedance-pH testing independently predicts 3-year pulmonary outcome and mortality in pulmonary fibrosis.
    J Gastroenterol Hepatol. 2023;38:1998-2005.
    PubMed     Abstract available
    
    
    
16. NABI Z, Ramchandani M, Basha J, Inavolu P, et al
    Per-oral endoscopic myotomy in cases with prior Heller's myotomy: Outcomes at a median follow-up of 5 years.
    J Gastroenterol Hepatol. 2023;38:2035-2039.
    PubMed     Abstract available
    
    
    October 2023
17. SHIMAMURA Y, Inoue H, Tanabe M, Ushikubo K, et al
    Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study.
    J Gastroenterol Hepatol. 2023 Oct 3. doi: 10.1111/jgh.16370.
    PubMed     Abstract available
    
    
    September 2023
18. ZENG SY, Wang J, Liu J, Lin MJ, et al
    Efficacy and safety of a 14-day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot study.
    J Gastroenterol Hepatol. 2023 Sep 13. doi: 10.1111/jgh.16348.
    PubMed     Abstract available
    
    
    August 2023
19. YU Y, Liao Z, Jiang X, Pan J, et al
    The use of magnet-controlled capsule endoscopy as the initial diagnostic tool in patients with acute upper gastrointestinal bleeding.
    J Gastroenterol Hepatol. 2023 Aug 3. doi: 10.1111/jgh.16310.
    PubMed     Abstract available
    
    
    
20. OHKI D, Tsuji Y, Kuroda R, Ushiku T, et al
    Gastrointestinal: A case of significant esophageal ulceration due to oral iron pill therapy.
    J Gastroenterol Hepatol. 2023;38:1241.
    PubMed    
    
    
    July 2023
21. YOU N, Chen Y, Yan X, Gu B, et al
    Persistent Helicobacter pylori infection leads to elevated fasting plasma glucose level: A retrospective cohort study based on a nondiabetes Chinese population.
    J Gastroenterol Hepatol. 2023 Jul 4. doi: 10.1111/jgh.16275.
    PubMed     Abstract available
    
    
    June 2023
22. EL HAGE CHEHADE N, Fu Y, Ghoneim S, Shah S, et al
    Association between obstructive sleep apnea and gastroesophageal reflux disease: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2023 Jun 10. doi: 10.1111/jgh.16245.
    PubMed     Abstract available
    
    
    April 2023
23. GULIYARA MA, Ermerak G, Levy M, Koo JH, et al
    Frailty predicts mortality in patients with Upper Gastrointestinal bleed: A prospective cohort study.
    J Gastroenterol Hepatol. 2023 Apr 1. doi: 10.1111/jgh.16188.
    PubMed     Abstract available
    
    
    March 2023
24. CHANG A, Rugivarodum M, Pungpipattrakul N, Akarapatima K, et al
    Role of Oral Iron Supplementation for Anemia Secondary to Acute Nonvariceal Upper Gastrointestinal Bleeding: A Randomized Controlled Trial.
    J Gastroenterol Hepatol. 2023 Mar 30. doi: 10.1111/jgh.16185.
    PubMed     Abstract available
    
    
    
25. SARUTA Y, Watanabe K, Tsuji T, Takahashi Y, et al
    Vonoprazan poses no additional risk of developing Clostridioides difficile infection compared to proton pump inhibitors.
    J Gastroenterol Hepatol. 2023 Mar 7. doi: 10.1111/jgh.16169.
    PubMed     Abstract available
    
    
    
26. MATSUURA N, Kato M, Irino T, Hirata K, et al
    Gastrointestinal: Ten-millimeter advanced duodenal cancer with a gastric phenotype.
    J Gastroenterol Hepatol. 2023;38:347.
    PubMed    
    
    
    February 2023
27. DUNNE CL, Kaur S, Delacruz B, Bresee LC, et al
    30-day Readmission Rates Among Upper Gastrointestinal Bleeds: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2023 Feb 20. doi: 10.1111/jgh.16153.
    PubMed     Abstract available
    
    
    
28. JO SY, Noh JH, Cha B, Ahn JY, et al
    Clinical outcomes of Dieulafoy's lesion compared to peptic ulcer in upper gastrointestinal bleeding.
    J Gastroenterol Hepatol. 2023 Feb 5. doi: 10.1111/jgh.16139.
    PubMed     Abstract available
    
    
    
29. ZHANG X, Sun K, Tang C, Cen L, et al
    LECT2 modulates dendritic cell function after Helicobacter pylori infection via the CD209a receptor.
    J Gastroenterol Hepatol. 2023 Feb 5. doi: 10.1111/jgh.16138.
    PubMed     Abstract available
    
    
    November 2022
30. JAVIER BF, Nicolas S, Virginia C, Karina E, et al
    Low-grade duodenal eosinophilia is associated with cagA in Helicobacter pylori related dyspepsia.
    J Gastroenterol Hepatol. 2022 Nov 5. doi: 10.1111/jgh.16051.
    PubMed     Abstract available
    
    
    
31. PARK SK, Kim MH, Jung JY, Oh CM, et al
    Change in smoking status and its relation to the risk of gastroduodenal ulcer in Korean men.
    J Gastroenterol Hepatol. 2022;37:2091-2097.
    PubMed     Abstract available
    
    
    October 2022
32. SIMADIBRATA DM, Syam AF, Lee YY
    A Comparison of Efficacy and Safety of Potassium Channel Acid Blocker and Proton Pump Inhibitor in Gastric Acid-related Diseases: A Systematic Review and Meta-analysis.
    J Gastroenterol Hepatol. 2022 Oct 1. doi: 10.1111/jgh.16017.
    PubMed     Abstract available
    
    
    September 2022
33. TAN ND, Liu XW, Liu CX, Li SB, et al
    The efficacy of keverprazan for duodenal ulcer: a phase II randomized, double-blind, parallel-controlled trial.
    J Gastroenterol Hepatol. 2022 Sep 6. doi: 10.1111/jgh.16000.
    PubMed     Abstract available
    
    
    August 2022
34. LI K, Cheng X, Jin R, Han T, et al
    The influence of different proton pump inhibitors and potassium-competitive acid blockers on indomethacin-induced small intestinal injury.
    J Gastroenterol Hepatol. 2022 Aug 8. doi: 10.1111/jgh.15973.
    PubMed     Abstract available
    
    
    
35. EUSEBI LH, Telese A, Cirota GG, Haidry R, et al
    Effect of gastro-esophageal reflux symptoms on the risk of Barrett's esophagus: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2022;37:1507-1516.
    PubMed     Abstract available
    
    
    July 2022
36. JUNG YS, Kim S, Kim HY, Noh SJ, et al
    7-day versus 14-day tegoprazan-based triple therapy to treat Helicobacter pylori infection: Real-world evidence.
    J Gastroenterol Hepatol. 2022 Jul 11. doi: 10.1111/jgh.15939.
    PubMed     Abstract available
    
    
    
37. WANG JW, Hsu PI, Lin MH, Kao JY, et al
    The efficacy of culture-guided versus empirical therapy with high-dose proton pump inhibitor as third-line treatment of Helicobacter pylori infection - A real-world clinical experience.
    J Gastroenterol Hepatol. 2022 Jul 11. doi: 10.1111/jgh.15942.
    PubMed     Abstract available
    
    
    June 2022
38. OUYANG Y, Wang M, Xu YL, Zhu Y, et al
    Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2022 Jun 18. doi: 10.1111/jgh.15917.
    PubMed     Abstract available
    
    
    May 2022
39. KAKIUCHI T, Okuda M, Matsuo M, Fujimoto K, et al
    Smart Gene as an effective noninvasive point-of-care test to detect Helicobacter pylori clarithromycin-resistant mutation.
    J Gastroenterol Hepatol. 2022 May 13. doi: 10.1111/jgh.15887.
    PubMed     Abstract available
    
    
    
40. PARK DH, In Seo S, Lee KJ, Kim J, et al
    Long-term proton pump inhibitor use and risk of osteoporosis and hip fractures: a nationwide population-based and multicenter cohort study using a common data model.
    J Gastroenterol Hepatol. 2022 May 2. doi: 10.1111/jgh.15879.
    PubMed     Abstract available
    
    
    
41. XIAO Y, Wu JCY, Lu CL, Tseng PH, et al
    Clinical practice guidelines for esophageal ambulatory reflux monitoring in Chinese adults.
    J Gastroenterol Hepatol. 2022;37:812-822.
    PubMed     Abstract available
    
    
    April 2022
42. HUANG Y, Chen J, Ding Z, Liang X, et al
    Susceptibility testing alone will not reliably achieve high Helicobacter pylori cure rates: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2022 Apr 17. doi: 10.1111/jgh.15864.
    PubMed     Abstract available
    
    
    March 2022
43. HOU X, Meng F, Wang J, Sha W, et al
    Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.
    J Gastroenterol Hepatol. 2022 Mar 27. doi: 10.1111/jgh.15837.
    PubMed     Abstract available
    
    
    
44. KUDO Y, Kudo SE, Miyachi H, Ichimasa K, et al
    Changes in halitosis value before and after Helicobacter pylori eradication: A single-institutional prospective study.
    J Gastroenterol Hepatol. 2022 Mar 24. doi: 10.1111/jgh.15835.
    PubMed     Abstract available
    
    
    
45. SCHUBERT JP, Woodman RJ, Mangoni AA, Rayner CK, et al
    Geospatial analysis of Helicobacter pylori infection in South Australia: should location influence eradication therapy?
    J Gastroenterol Hepatol. 2022 Mar 21. doi: 10.1111/jgh.15832.
    PubMed     Abstract available
    
    
    
46. YANG W, Yusufu Y, Wang C
    Gastrointestinal: A rare case of upper gastrointestinal bleeding: Splenosis mimicking gastric varices.
    J Gastroenterol Hepatol. 2022 Mar 1. doi: 10.1111/jgh.15795.
    PubMed    
    
    
    February 2022
47. KHAN R, Saha S, Gimpaya N, Bansal R, et al
    Outcomes for upper gastrointestinal bleeding during the first wave of the COVID-19 pandemic in the Toronto area.
    J Gastroenterol Hepatol. 2022 Feb 16. doi: 10.1111/jgh.15804.
    PubMed     Abstract available
    
    
    
48. TERASAKI K, Ueno A, Mizuno C, Shima T, et al
    Gastrointestinal: Pembrolizumab-induced gastric ulcer occurring as an immune-related adverse event.
    J Gastroenterol Hepatol. 2022 Feb 9. doi: 10.1111/jgh.15788.
    PubMed    
    
    
    December 2021
49. MANEERATTANAPORN M, Pittayanon R, Patcharatrakul T, Bunchorntavakul C, et al
    Thailand Guideline 2020 for Medical Management of Gastroesophageal Reflux Disease (GERD).
    J Gastroenterol Hepatol. 2021 Dec 14. doi: 10.1111/jgh.15758.
    PubMed    
    
    
    
50. KOUNTOURAS J, Doulberis M, Polyzos SA, Kazakos E, et al
    Impact of Helicobacter pylori-related metabolic syndrome with hyperhomocysteinemia on extragastric pathologies.
    J Gastroenterol Hepatol. 2021 Dec 10. doi: 10.1111/jgh.15753.
    PubMed    
    
    
    
51. REN S, Cai P, Liu Y, Wang T, et al
    Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2021 Dec 3. doi: 10.1111/jgh.15751.
    PubMed     Abstract available
    
    
    October 2021
52. YONGWATANA K, Harinwan K, Chirapongsathorn S, Opuchar K, et al
    Curcuma longa Linn Versus Omeprazole in Treatment of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    J Gastroenterol Hepatol. 2021 Oct 15. doi: 10.1111/jgh.15705.
    PubMed     Abstract available
    
    
    
53. BUNCHORNTAVAKUL C, Buranathawornsom A
    Randomized Clinical Trial: 7-day Vonoprazan-based versus 14-day Omeprazole-based Triple Therapy for Helicobacter pylori.
    J Gastroenterol Hepatol. 2021 Oct 7. doi: 10.1111/jgh.15700.
    PubMed     Abstract available
    
    
    August 2021
54. UENO M, Mano T, Kayahara T, Mizuno M, et al
    Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding: It's time to step forward.
    J Gastroenterol Hepatol. 2021 Aug 8. doi: 10.1111/jgh.15652.
    PubMed    
    
    
    
55. SIKAVI DR, Cai JX, Carroll TL, Chan WW, et al
    Prevalence and clinical significance of esophageal motility disorders in patients with laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2021;36:2076-2082.
    PubMed     Abstract available
    
    
    July 2021
56. CHO JH, Jin SY, Park S
    Scoring model for discriminating gastric cancer risk in patients with negative serum pepsinogen and anti-Helicobacter pylori antibody results.
    J Gastroenterol Hepatol. 2021 Jul 19. doi: 10.1111/jgh.15630.
    PubMed     Abstract available
    
    
    
57. CHEN Y, Xu C, Xu H, Chen W, et al
    Persistent Helicobacter pylori infection for more than 3 years leads to elevated serum homocysteine concentration: a retrospective cohort study based on a healthy Chinese population.
    J Gastroenterol Hepatol. 2021 Jul 1. doi: 10.1111/jgh.15603.
    PubMed     Abstract available
    
    
    
58. SUNG JJ
    Clopidogrel is no better or worse than aspirin when combined with proton pump inhibitors in the prevention of major adverse event. Is the jury out?
    J Gastroenterol Hepatol. 2021;36:1733-1734.
    PubMed    
    
    
    June 2021
59. HUSSEIN M, Alzoubaidi D, O'Donnell M, de la Serna A, et al
    Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes.
    J Gastroenterol Hepatol. 2021 Jun 15. doi: 10.1111/jgh.15579.
    PubMed     Abstract available
    
    
    
60. GINGOLD-BELFER R, Niv Y, Schmilovitz-Weiss H, Levi Z, et al
    Susceptibility-Guided vs Empirical Treatment for Helicobacter pylori infection: a Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2021 Jun 11. doi: 10.1111/jgh.15575.
    PubMed     Abstract available
    
    
    
61. HORII T, Suzuki S, Takano C, Shibuya H, et al
    Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2021 Jun 9. doi: 10.1111/jgh.15572.
    PubMed     Abstract available
    
    
    May 2021
62. JEON HJ, Moon HS, Kwon IS, Kang SH, et al
    Which scoring system should be used for non-variceal upper gastrointestinal bleeding? Old or New?
    J Gastroenterol Hepatol. 2021 May 24. doi: 10.1111/jgh.15555.
    PubMed     Abstract available
    
    
    March 2021
63. QIAO C, Li Y, Liu J, Ji C, et al
    Clarithromycin versus furazolidone for naive Helicobacter pylori infected patients in a high clarithromycin resistance area.
    J Gastroenterol Hepatol. 2021 Mar 10. doi: 10.1111/jgh.15468.
    PubMed     Abstract available
    
    
    
64. KODAMA M, Okimoto T, Mizukami K, Hirashita Y, et al
    Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: a long-term prospective follow-up study.
    J Gastroenterol Hepatol. 2021 Mar 3. doi: 10.1111/jgh.15477.
    PubMed     Abstract available
    
    
    February 2021
65. AKADA J, Tshibangu-Kabamba E, Tuan VP, Kurogi S, et al
    Serum Helicobacter pylori antibody reactivity in seven Asian countries using an automated latex aggregation turbidity assay.
    J Gastroenterol Hepatol. 2021 Feb 20. doi: 10.1111/jgh.15467.
    PubMed     Abstract available
    
    
    January 2021
66. KATO M, Hayashi Y, Nishida T, Oshita M, et al
    Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis.
    J Gastroenterol Hepatol. 2021 Jan 5. doi: 10.1111/jgh.15396.
    PubMed     Abstract available
    
    
    
67. NIIKURA R, Aoki T, Kojima T, Kawahara T, et al
    Natural history of upper and lower gastrointestinal bleeding in hemodialysis patients: A dual-center long-term cohort study.
    J Gastroenterol Hepatol. 2021;36:112-117.
    PubMed     Abstract available
    
    
    November 2020
68. YANG SC, Wu CK, Tai WC, Liang CM, et al
    Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding.
    J Gastroenterol Hepatol. 2020 Nov 28. doi: 10.1111/jgh.15360.
    PubMed     Abstract available
    
    
    
69. SCHUBERT JP, Gehlert J, Rayner CK, Roberts-Thomson IC, et al
    Antibiotic Resistance of Helicobacter pylori in Australia and New Zealand: A Systematic Review and Meta-analysis.
    J Gastroenterol Hepatol. 2020 Nov 20. doi: 10.1111/jgh.15352.
    PubMed     Abstract available
    
    
    October 2020
70. GINGOLD-BELFER R, Niv Y, Levi Z, Boltin D, et al
    Rifabutin triple therapy for first-line and rescue treatment of Helicobacter pylori infection: a systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2020 Oct 10. doi: 10.1111/jgh.15294.
    PubMed     Abstract available
    
    
    
71. TANG C, Zhu Y, Yang X, Xu B, et al
    Upper gastrointestinal mucosal injury associated with ticagrelor plus aspirin, ticagrelor alone, or aspirin alone at 1-year after coronary artery bypass grafting.
    J Gastroenterol Hepatol. 2020;35:1720-1730.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge.